Your shortcut for this week:
Read on for the foresight of the week and the full breakdown of what shaped healthcare AI 👇
Solutions and Launches
OpenAI (US): Launched ChatGPT for Clinicians with HealthBench Professional, a physician-designed benchmark. In testing, 99.6% of responses were rated safe and accurate by clinicians. [Link]
Google (US): Released MedGemma, a collection of open models optimized for medical text and imaging tasks. The models are designed as a foundation for building clinical applications, including use within privacy-preserving, locally deployed systems. [Link]
OpenMed (Open-source): Released OpenMed 1.2.0 with MLX-native privacy filtering and clinical entity extraction for local medical text workflows on Apple Silicon. The release supports on-device de-identification, reducing the need to send clinical text to external cloud APIs. [Link]
Viz.ai (US): Announced a strategic collaboration with Johnson & Johnson to expand access to its FDA-cleared subdural hemorrhage AI solution across US hospitals. [Link]
Betterness (US): Raised $2.5M seed and launched Bett-i, a voice-first AI life-coaching system that connects wearables, labs and specialist wellness agents. [Link]
Governance, Policy, and Ethics
European Commission (EU): Opened €63.2M in Digital Europe calls, including €9M for AI-powered medical image screening and €24M for digital health services under the European Health Data Space. [Link]
WHO/Europe (EU): Reported that nearly three quarters of EU Member States use AI-assisted diagnostics, while 63% use chatbots for patient engagement. The report stresses workforce training, governance and public trust as adoption moves into routine health systems. [Link]
Research and AI Advancements
Early attention deficit hyperactivity disorder prediction from longitudinal electronic health records: An EHR foundation model, fine-tuned on 140,000 pediatric records, predicted ADHD up to 4 years in advance with a time-dependent AUROC of 0.92. [Link]
AI Triage of Normal Chest Radiographs: A Silent Trial and Failure Analysis: A multicentre NHS silent trial found that AI could potentially deprioritise around 20% of chest radiographs, with an estimated clinically significant miss rate of 0.05%. [Link]
Using a large language model artificial intelligence agent to improve the efficiency of clinical quality measure evidence evaluation: An LLM agent reviewed evidence for a clinical quality measure in about 5 hours, with 69% agreement with expert judgement. [Link]
Leveraging artificial intelligence for surgical site infection surveillance: A comparison of 5 large language models: Five LLMs detected surgical site infections with 90–95% accuracy in a small retrospective study of 40 abdominal surgery patients. [Link]
Development and validation of a machine learning model for predicting positive blood cultures using vital signs in ICU patients: A vital-sign-only model predicted positive blood cultures in febrile ICU patients with moderate external performance (AUROC 0.679). [Link]
Ernst & Young & RCPI (Ireland): Found 58% of Irish doctors used AI clinically in the past year, with widespread use of generative tools for documentation, diagnosis support and summarisation. [Link]
Partnerships & Adoption
Merck / MSD (US): Announced a multi-year Google Cloud partnership worth up to $1B to deploy Gemini Enterprise across R&D, manufacturing, commercial and corporate workflows. [Link]
Corti (Denmark): Expanded its partnership with Dedalus to bring AI-powered clinical documentation into the ORBIS hospital platform across Europe. [Link]
Welldoc (US): Selected for the CMS ACCESS Model, linking its AI-powered cardiometabolic platform to outcome-aligned payments for chronic disease management. [Link]
Bets on the Next Health System
Investments:
AcuityMD (US): Raised $80M to add agentic AI capabilities to its commercial intelligence platform for medical device teams. [Link]
Courier Health (US): Raised $50M Series B to expand its platform helping biopharma companies manage patient journeys, using AI to automate workflows and identify patients at risk of dropping off treatment. [Link]
Tava Health (US): Raised $40M Series C and launched Symphony, an AI-enabled practice platform for behavioural health providers with scribing, treatment planning, scheduling and telehealth. [Link]
Amperos Health (US): Raised $16M Series A to expand its AI-native denial management and revenue recovery platform for healthcare providers. [Link]
Almanac Health (US): Raised $10M to build evidence-grounded clinical decision support for clinicians, designed to integrate with existing EHR workflows. [Link]
M&A:
ŌURA (Finland): Acquired Galen AI, a YC-backed startup that connects wearable data with medical records across 800+ institutions. The move pushes Oura further from wellness tracking toward a more longitudinal personal health platform. [Link]
IKS Health (India/US): Agreed to acquire TruBridge, extending its AI-enabled care operations platform into rural and community healthcare. [Link]
That’s a wrap for Edition #29 of Health AI Foresight.
My goal with this newsletter is simple - to connect the present, the emerging, and the future of healthcare AI.
See you next week.
- Dr. Aboufandi
📩 Something stand out? Or have a suggestion? Hit reply - I read every message.